Alzheimer’s disease (AD) is characterized by a cascade of molecular and neurodegenerative brain changes, in which Aβ plaques start to accumulate ~20 years before symptom onset followed by the accumulation and spreading of neurofibrillary tau aggregates with ensuing neurodegeneration and AD dementia1,2. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.